Restoration of reversed whole PTH/intact PTH ratio and reduction in parathyroid gland vascularity during cinacalcet therapy for severe hyperparathyroidism in a uraemic patient

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 638-641

  Komaba, Hirotaka ^a   Shin, Jeongsoo ^b   Fukagawa, Masafumi ^a,c  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Motomachi HD Clinic   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cinacalcet hydrochloride; Intact PTH assay; N PTH; Whole PTH assay

Indexed keywords

22 OXACALCITRIOL; CINACALCET; PARATHYROID HORMONE; REGPARA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; HEMODIALYSIS PATIENT; HUMAN; MALE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; UREMIA; VASCULARIZATION;

HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID GLANDS; PARATHYROID HORMONE; SEVERITY OF ILLNESS INDEX; UREMIA;

EID: 75649090782     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp578     Document Type: Article

References (16)

1. John MR, Goodman WG, Gao P et al. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 1999; 84: 4287-4290
2. Nakanishi S, Kazama JJ, Shigematsu T et al. Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients. Am J Kidney Dis 2001; 38 (Suppl 1): S172-S174
3. Kazama JJ, Omori K, Higuchi N et al. Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2004; 19: 892-897
4. Martin KJ, Jüppner H, Sherrard DJ et al. First-and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int 2005; 68: 1236-1243
5. D'Amour P, Brossard JH, Rousseau L et al. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathy-roidism. Clin Chem 2003; 49: 2037-2044
6. Rubin MR, Silverberg SJ, D'Amour P et al. An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1-84) is overproduced in parathyroid carcinoma. Clin Chem 2007; 53: 1470-1476
7. Arakawa T, D'Amour P, Rousseau L et al. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia. Clin J Am Soc Nephrol 2006; 1: 525-531
8. Komaba H, Takeda Y, Abe T et al. Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH/intact PTH ratio in a haemodialysis patient. Nephrol Dial Transplant 2008; 23: 1760-1762
9. Komaba H, Takeda Y, Shin J et al. Reversed whole PTH/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review. NDT Plus 2008; 1 (Suppl 3): iii54-iii58
10. D'Amour P, Brossard JH, Rakel A et al.Evidence that the aminotermi-nal composition of non-(1-84) parathyroid hormone fragments starts before position 19. Clin Chem 2005; 51: 169-176
11. D'Amour P. Circulating PTH molecular forms: what we know and what we don't. Kidney Int 2006; 70 (Suppl 102): S29-S33
12. Block GA, Martin KJ, de Francisco AL et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516-1525
13. Kawata T, Imanishi Y, Kobayashi K et al. Direct in vitro evidence of extracellular Ca2-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells. J Clin En-docrinol Metab 2005; 90: 5774-5778
14. Valle C, Rodriguez M, Santamaŕia R et al. Cinacalcet reduces the set point of the PTH-calcium curve. J Am Soc Nephrol 2008; 19: 2430-2436
15. D'Amour P, Räkel A, Brossard JH et al. Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays. J Clin Endocrinol Metab 2006; 91: 283-289
16. Meola M, Petrucci I, Barsotti G. Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol Dial Transplant 2009; 24: 982-989